Publication in detail

Development. 2018 Jan 22. pii: dev.160382. doi: 10.1242/dev.160382. [Epub ahead of print]

Podoplanin regulates mammary stem cell function and tumorigenesis by potentiatingWnt/β-catenin signaling.

Bresson, L; Faraldo, MM; Di-Cicco, A; Quintanilla, M; Glukhova, MA; Deugnier, MA

Institut Curie, PSL Research University, CNRS, UMR144, Paris, F-75248, France. Université Paris Sud, Université Paris-Saclay, F-91405 Orsay, France. Sorbonne Universités, UPMC Univ Paris 06, F-75005, Paris, France. Equipe labelisée Ligue Nationale Contre le Cancer, 2013, France. INSERM, Paris, F-75013, France. Instituto de Investigaciones Biomedicas Alberto Sols , CSIC-UAM, Madrid, Spain.

Stem cells (SC) drive mammary development, giving rise postnatally to an epithelial bilayer composed of luminal and basal myoepithelial cells. Deregulation of SCs is thought to be at the origin of certain breast cancers, however the molecular identity of SCs and the factors regulating their function remain poorly defined. We identified the transmembrane protein, Podoplanin (Pdpn), as a specific marker of the basal compartment, including multipotent SCs, and found Pdpn localized at the basal-luminal interface. Embryonic deletion of Pdpn targeted to basal cells diminished basal and luminal SC activity and affected expression of several Wnt/β-catenin (Wnt/β-cat) signaling components in basal cells. Moreover, Pdpn loss attenuated mammary tumor formation in a mouse model of β-cat-induced breast cancer, limiting tumor-initiating cell expansion and promoting molecular features associated with mesenchymal-to-epithelial cell transition. In line with the loss-of-function data, we demonstrated that mechanistically, Pdpn enhanced Wnt/β-cat signaling in mammary basal cells. Overall, this study uncovers a role for Pdpn in mammary SC function and importantly, identifies Pdpn as a new regulator of Wnt/β-cat signaling, a key pathway in mammary development and tumorigenesis.

» Online Version

Proven Track Record

The team at Ozgene has over two decades of experience creating customised knockout and knock-in mice for pivotal medical research globally. Over 400 scientific publications are based on research using Ozgene mice.

Go to Publications

Global Client Base

Ozgene generates genetically customised mice for researchers around the world. Ozgene mice can be found in 31 different countries on 5 continents from small academic institutions to multinational pharmaceutical companies.

See Client Papers

Lean Management

Ozgene is applying Lean Management principles to deliver the highest quality services and shortest lead times to our customers. The implementation of Lean Culture has already seen an improvement in our processes and timelines.

Read More